UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
September
18, 2006
Date
of
Report (Date of earliest event reported)
KIWA
BIO-TECH PRODUCTS GROUP CORPORATION
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-33167
|
84-0448400
|
|
(State
or other
jurisdiction
|
(Commission
|
(I.R.S.
Employer
|
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
415
West Foothill Blvd, Suite 206,
Claremont, California 91711-2766
(Address
of principal executive offices)
(909)
626-2358
(Registrant’s
telephone number, including area code)
N/A
(Former
Name or Former Address, if changed since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
| o |
Written communications pursuant to Rule 425 under
the
Securities Act (17 CFR 230.425) |
| o |
Soliciting material pursuant to Rule 14a-12 under
the
Exchange Act (17 CFR 240.14a-12) |
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item
5.02 Departure
of Principal Officers; Appointment of Principal Officers
On
September 18, 2006, our Board of Directors appointed Juhua Wang as Chief
Operating Officer after accepting the resignation of Johnson Lau.
Juhua
Wang previously worked as the Vice General Manager of Shenyin Wanguo Securities
Co. Ltd, Beijing Administrative Department and as the Manager of Beijing
Jingsong Branch. Prior to that, she worked as the Vice Manager of Shanghai
Wanguo Securities Northeast Administrative Department and the Manager of its
Ha'erbin Sales Department. She was also Chief Economic Engineer of Ha'erbin
Investment Group, Mechanic and Electrical Investment Co. Ms. Wang graduated
from
the Administrative Department of Ha'erbin Industry University with a Masters
degree.
On
September 18, 2006, our Board of Directors appointed Xiaonan Wu as our Vice
President after accepting the resignation of Jinghong Zhang.
Mr.
Xiaonan Wu has 17 years of experience in medical product distribution and market
operations. He has substantial experience and resources in market development
including work arising from his employment with Beijing Medicine Economical
Technology Management Company as the General Manager Assistant and Assistant
Manager in charge of drugs, and later as its Deputy General Manager.
Mr.
Wu
has also served as the Deputy General Manager of Beijing Medicine Limited
Liability Company. At the same time he was the General Manager of its
subordinate Medicine Guarantee Brand - New Pharmacy Chain Company as well as
the
General Manager of its subordinate joint-venture pharmaceutical company, Beijing
Unit Medicine Company. Mr. Wu graduated from the College of Pharmacy, Beijing
Medical University with a Bachelor of Science degree.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date:
September 20, 2006
| By: |
/s/
Wei Li
|
| Name: |
Wei
Li |
|
| Title: |
Chairman
of Board of Directors and Chief Executive
Officer |